SEC Filings

Filing date Form Description View
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
EFFECT

EFFECT

View HTML

Data provided by Kaleidoscope.

 

 

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools